Abstract
Purpose
To highlight and compare experts’ laser settings during endoscopic laser treatment of upper tract urothelial carcinoma (UTUC), to identify measures to reduce complications, and to propose guidance for endourologists.
Methods
Following a focused literature search to identify relevant questions, a survey was sent to laser experts. We asked participants for typical settings during specific scenarios (ureteroscopy (URS), retrograde intrarenal surgery (RIRS), and percutaneous treatment). These settings were compared among the reported laser types to find common settings and limits. Additionally, we identified preventive measures commonly applied during surgery.
Results
Twenty experts completed the survey, needing a mean time of 12.7 min. Overall, most common laser type was Holmium–Yttrium–Aluminum–Garnet (Ho:YAG) (70%, 14/20) followed by Thulium fiber laser (TFL) (45%, 9/20), pulsed Thulium–Yttrium–Aluminum–Garnet (Tm:YAG) (3/20, 15%), and continuous wave (cw)Tm:YAG (1/20, 5%). Pulse energy for the treatment of distal ureteral tumors was significantly different with median settings of 0.9 J, 1 J and 0.45 J for Ho:YAG, TFL and pulsed Tm:YAG, respectively (p = 0.048). During URS and RIRS, pulse shapes were significantly different, with Ho:YAG being used in long pulse and TFL in short pulse mode (all p < 0.05). We did not find further disparities.
Conclusion
Ho:YAG is used by most experts, while TFL is the most promising alternative. Laser settings largely do not vary significantly. However, further research with novel lasers is necessary to define the optimal approach. With the recent introduction of small caliber and more flexible scopes, minimal-invasive UTUC treatment is further undergoing an extension of applicability in appropriately selected patients.
Similar content being viewed by others
Data availability
The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.
References
Rouprêt M, Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM et al (2021) European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update. Eur Urol 79(1):62–79. https://doi.org/10.1016/j.eururo.2020.05.042
Baard J, Freund JE, de la Rosette JJ, Laguna MP (2017) New technologies for upper tract urothelial carcinoma management. Curr Opin Urol 27(2):170–175. https://doi.org/10.1097/mou.0000000000000373
Jung H, Giusti G, Fajkovic H, Herrmann T, Jones R, Straub M et al (2019) Consultation on UTUC, Stockholm 2018: aspects of treatment. World J Urol 37(11):2279–2287. https://doi.org/10.1007/s00345-019-02811-w
Villa L, Haddad M, Capitanio U, Somani BK, Cloutier J, Doizi S et al (2018) Which patients with upper tract urothelial carcinoma can be safely treated with flexible ureteroscopy with holmium: YAG laser photoablation? Long-term results from a high volume institution. J Urol 199(1):66–73. https://doi.org/10.1016/j.juro.2017.07.088
Sanguedolce F, Fontana M, Turco M, Territo A, Lucena JB, Cortez JC et al (2021) Endoscopic management of upper urinary tract urothelial carcinoma: oncologic outcomes and prognostic factors in a contemporary cohort. J Endourol 35(11):1593–1600. https://doi.org/10.1089/end.2021.0133
Defidio L, Antonucci M, De Dominicis M, Fuchs G, Patel A (2019) Thulium-holmium: YAG duo laser in conservative upper tract urothelial cancer treatment: 13 years experience from a tertiary national referral center. J Endourol 33(11):902–908. https://doi.org/10.1089/end.2019.0308
Breda A, Territo A, Sanguedolce F (2020) Combination of holmium and thulium laser ablation in upper tract urothelial carcinoma. World J Urol 38(10):2661–2662. https://doi.org/10.1007/s00345-020-03124-z
Musi G, Mistretta FA, Marenghi C, Russo A, Catellani M, Nazzani S et al (2018) Thulium laser treatment of upper urinary tract carcinoma: a multi-institutional analysis of surgical and oncological outcomes. J Endourol 32(3):257–263. https://doi.org/10.1089/end.2017.0915
Wen J, Ji ZG, Li HZ (2018) Treatment of upper tract urothelial carcinoma with ureteroscopy and thulium laser: a retrospective single center study. BMC Cancer 18(1):196. https://doi.org/10.1186/s12885-018-4118-y
Proietti S, Johnston T, Pupulin M, Di Pietro S, Spagna S, Rico L et al (2022) Effectiveness and safety of thulium fiber laser in the conservative management of patients with upper tract urothelial carcinoma. Eur Urol Open Sci 46:99–104. https://doi.org/10.1016/j.euros.2022.10.010
Taratkin M, Singla N, Babaevskaya D, Androsov A, Shariat SF, Fajkovic H et al (2023) A review of how lasers are used in UTUC surgery: can the choice of laser affect outcomes? Cancers. https://doi.org/10.3390/cancers15061874
Falagas ME, Pitsouni EI, Malietzis GA, Pappas G (2008) Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J 22(2):338–342. https://doi.org/10.1096/fj.07-9492LSF
Enikeev D, Taratkin M (2023) Thulium fiber laser: bringing lasers to a whole new level. Eur Urol Open Sci 48:31–33. https://doi.org/10.1016/j.euros.2022.07.007
Taratkin M, Kovalenko A, Laukhtina E, Paramonova N, Spivak L, Wachtendorf LJ et al (2022) Ex vivo study of Ho: YAG and thulium fiber lasers for soft tissue surgery: which laser for which case? Lasers Med Sci 37(1):149–154. https://doi.org/10.1007/s10103-020-03189-7
Proietti S, Rodríguez-Socarrás ME, Eisner BH, Lucianò R, Basulto Martinez MJ, Yeow Y et al (2021) Thulium:YAG versus holmium: YAG laser effect on upper urinary tract soft tissue: evidence from an ex vivo experimental study. J Endourol 35(4):544–551. https://doi.org/10.1089/end.2020.0222
Ortner G, Rice P, Nagele U, Herrmann TRW, Somani BK, Tokas T (2023) Tissue thermal effect during lithotripsy and tissue ablation in endourology: a systematic review of experimental studies comparing Holmium and Thulium lasers. World J Urol 41(1):1–12. https://doi.org/10.1007/s00345-022-04242-6
Huusmann S, Lafos M, Meyenburg I, Muschter R, Teichmann HO, Herrmann T (2021) Tissue effects of a newly developed diode pumped pulsed Thulium:YAG laser compared to continuous wave thulium: YAG and pulsed holmium: YAG laser. World J Urol 39(9):3503–3508. https://doi.org/10.1007/s00345-021-03634-4
Becker B, Enikeev D, Glybochko P, Rapoport L, Taratkin M, Gross AJ et al (2020) Effect of optical fiber diameter and laser emission mode (cw vs pulse) on tissue damage profile using 1.94 µm Tm: fiber lasers in a porcine kidney model. World J Urol 38(6):1563–1568. https://doi.org/10.1007/s00345-019-02944-y
Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P et al (2006) Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology 67(6):1181–1187. https://doi.org/10.1016/j.urology.2005.12.034
Rouprêt M, Traxer O, Tligui M, Conort P, Chartier-Kastler E, Richard F et al (2007) Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol 51(3):709–713. https://doi.org/10.1016/j.eururo.2006.07.019. (discussion 14)
Villa L, Cloutier J, Letendre J, Ploumidis A, Salonia A, Cornu JN et al (2016) Early repeated ureteroscopy within 6–8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings. World J Urol 34(9):1201–1206. https://doi.org/10.1007/s00345-015-1753-7
Ortner G, Pang KH, Yuan Y, Herrmann TRW, Biyani CS, Tokas T (2023) Peri- and post-operative outcomes, complications, and functional results amongst different modifications of endoscopic enucleation of the prostate (EEP): a systematic review and meta-analysis. World J Urol. https://doi.org/10.1007/s00345-023-04308-z
Gauhar V, Gilling P, Pirola GM, Chan VW, Lim EJ, Maggi M et al (2022) Does MOSES technology enhance the efficiency and outcomes of standard holmium laser enucleation of the prostate? Results of a Systematic review and meta-analysis of comparative studies. Eur Urol Focus 8(5):1362–1369. https://doi.org/10.1016/j.euf.2022.01.013
Enikeev D, Taratkin M, Azilgareeva C, Glybochko P (2020) Knowing the inside of a laser. Arch Esp Urol 73(8):665–674
Mertens LS, Sharma V, Matin SF, Boorjian SA, Houston Thompson R, van Rhijn BWG et al (2023) Bladder recurrence following upper tract surgery for urothelial carcinoma: a contemporary review of risk factors and management strategies. Eur Urol Open Sci 49:60–66. https://doi.org/10.1016/j.euros.2023.01.004
Yonese I, Ito M, Waseda Y, Kobayashi S, Toide M, Takazawa R et al (2023) Impact of diagnostic ureteral catheterization on intravesical tumour recurrence following radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. https://doi.org/10.1007/s00345-023-04446-4
Douglawi A, Ghoreifi A, Lee R, Yip W, Seyedian SSL, Ahmadi H et al (2022) Bladder recurrence following diagnostic ureteroscopy in patients undergoing nephroureterectomy for upper tract urothelial cancer: is ureteral access sheath protective? Urology 160:142–146. https://doi.org/10.1016/j.urology.2021.11.026
Tokas T, Skolarikos A, Herrmann TRW, Nagele U (2019) Pressure matters 2: intrarenal pressure ranges during upper-tract endourological procedures. World J Urol 37(1):133–142. https://doi.org/10.1007/s00345-018-2379-3
Rice P, Somani BK, Nagele U, Herrmann TRW, Tokas T (2022) Generated temperatures and thermal laser damage during upper tract endourological procedures using the holmium: yttrium-aluminum-garnet (Ho: YAG) laser: a systematic review of experimental studies. World J Urol 40(8):1981–1992. https://doi.org/10.1007/s00345-022-03992-7
Fero KE, Shan Y, Lec PM, Sharma V, Srinivasan A, Movva G et al (2021) Treatment patterns, outcomes, and costs associated with localized upper tract urothelial carcinoma. JNCI Cancer Spectr. https://doi.org/10.1093/jncics/pkab085
Funding
None.
Author information
Authors and Affiliations
Contributions
GO and TT had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: TT. Acquisition of data: GO, TT, BKS, SG, GK, OT, GG, SP, EL, PK, ØU, IKG, MD, JB, GMK, SF, LD, LV, AM, TT, AP, SBH, AP, ASG, TH, UN. Analysis and interpretation: GO, TT. Drafting of the manuscript: GO, TT. Critical revision of the manuscript: TT, BKS, SG, TH, UN, ASG. Statistical analysis: GO. Obtaining funding: None. Administrative, technical, or material support: GO, TT, UN, TH. Supervision: TT.
Corresponding author
Ethics declarations
Conflict of interest
Gernot Ortner certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g., employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: None. Thomas Tailly: Consultant Boston Scientific, Cook Medical, Dornier, Storz. Guido Kamphuis: Advisory board: Boston Scientific, Olympus, Honoraria: Alnylam, Boston Scientific, Coloplast Porgès, Olympus. Amelia Pietropaolo: Consultant Boston Scientific, Ambu, Pusen. Panagiotis Kallidonis: Consultant Cook Medical, EMS. Mordechai Duvdevani: Consultant Boston Scientific. Udo Nagele: Consultant Baxter, Boston Scientific, Optimed, Storz medical, B + K. Laurian Dragos: Consultant EMS, Boston Scientific, Ambu. Silvia Proietti: Consultant Boston Scientific. Joyce Baard: Consultant Coloplast, Boston Scientific, Olympus, Urogen. Øyvind Ulvik: Lectures Olympus.
Research involving human participants and/or animals
This review does not involve human participants and/or animals.
Informed consent
No patients were included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ortner, G., Somani, B.K., Güven, S. et al. Experts’ recommendations in laser use for the treatment of upper tract urothelial carcinoma: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training Research in Urological Surgery and Technology (T.R.U.S.T.) group. World J Urol 41, 3367–3376 (2023). https://doi.org/10.1007/s00345-023-04632-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-023-04632-4